ACAD
36.32
+0.49
+1.37%
AEMD
0.989
+0.009
+0.9082%
APRI
1.82
0.00
0.00%
ARNA
27.28
-0.03
-0.11%
ATEC
4.15
+0.03
+0.73%
CNAT
5.06
+0.05
+1.00%
CRXM
0.137
+0.034
+32.9767%
CYTX
0.5
+0.03
+7.53%
DXCM
44.78
-0.2
-0.44%
GNMK
7.92
+0.08
+1.02%
HALO
17.82
+0.05
+0.28%
ILMN
209.88
+4.7
+2.29%
INNV
0.087
0.00
0.00%
INO
6.23
-0.02
-0.32%
ISCO
1.65
+0.11
+7.14%
ISIS
57.56
0.00
0.00%
LGND
143.93
+0.58
+0.40%
LPTN
2.93
-2.93
-100.00%
MBVX
0.71
-0.03
-4.0146%
MEIP
2.68
+0.06
+2.29%
MNOV
6.14
-0.05
-0.81%
MRTX
15.75
+0.2
+1.29%
MSTX
0.13
-0.01
0.00%
NBIX
59.03
+0.07
+0.12%
NUVA
55.05
+0.48
+0.88%
ONCS
1.251
-0.039
-3.023%
ONVO
1.61
+0.21
+15.00%
OREX
1.78
-0.04
-2.20%
OTIC
3.45
-0.02
-0.72%
QDEL
41.77
-0.18
-0.43%
RCPT
231.96
0.00
0.00%
RGLS
1.21
-0.04
-3.20%
RMD
79
+0.21
+0.27%
SCIE
0
+0.00
+50.0000%
SPHS
2.33
+0.09
+4.02%
SRNE
2.8
+0.3
+12.00%
TROV
0.805
-0.004
-0.519%
VICL
2.38
0.00
0.00%
VOLC
18
0.00
0.00%
ZGNX
39.75
+0.1
+0.25%
ACAD
36.32
+0.49
+1.37%
AEMD
0.989
+0.009
+0.9082%
APRI
1.82
0.00
0.00%
ARNA
27.28
-0.03
-0.11%
ATEC
4.15
+0.03
+0.73%
CNAT
5.06
+0.05
+1.00%
CRXM
0.137
+0.034
+32.9767%
CYTX
0.5
+0.03
+7.53%
DXCM
44.78
-0.2
-0.44%
GNMK
7.92
+0.08
+1.02%
HALO
17.82
+0.05
+0.28%
ILMN
209.88
+4.7
+2.29%
INNV
0.087
0.00
0.00%
INO
6.23
-0.02
-0.32%
ISCO
1.65
+0.11
+7.14%
ISIS
57.56
0.00
0.00%
LGND
143.93
+0.58
+0.40%
LPTN
2.93
-2.93
-100.00%
MBVX
0.71
-0.03
-4.0146%
MEIP
2.68
+0.06
+2.29%
MNOV
6.14
-0.05
-0.81%
MRTX
15.75
+0.2
+1.29%
MSTX
0.13
-0.01
0.00%
NBIX
59.03
+0.07
+0.12%
NUVA
55.05
+0.48
+0.88%
ONCS
1.251
-0.039
-3.023%
ONVO
1.61
+0.21
+15.00%
OREX
1.78
-0.04
-2.20%
OTIC
3.45
-0.02
-0.72%
QDEL
41.77
-0.18
-0.43%
RCPT
231.96
0.00
0.00%
RGLS
1.21
-0.04
-3.20%
RMD
79
+0.21
+0.27%
SCIE
0
+0.00
+50.0000%
SPHS
2.33
+0.09
+4.02%
SRNE
2.8
+0.3
+12.00%
TROV
0.805
-0.004
-0.519%
VICL
2.38
0.00
0.00%
VOLC
18
0.00
0.00%
ZGNX
39.75
+0.1
+0.25%
Home » Archive by Category

Xconomy

As Big Cancer Trials Ramp Up, Grail Goes Global, Merges With Cirina

May 31, 2017 – 4:45 am

Grail, the Illumina (NASDAQ: ILMN) spinout aiming to develop a blood test that can detect cancer at its earliest stages, has gone global. The Menlo Park, CA, startup, is merging with China’s Cirina,…

[[Click headline to continue reading.]]

In Maine, Making Cancer DNA Tests Free—And Asking Tough Questions

May 31, 2017 – 2:35 am

Has the era of genetic oncology arrived? Last week, the biomedical world took a notable step in that direction when the FDA said Merck’s drug pembrolizumab (Keytruda), already one of the…

[[Click headline to continue reading.]]

RNA Specialist Arcturus Therapeutics Gets $3M R&D Grant for CF Drug

May 30, 2017 – 12:05 pm

San Diego-based Arcturus Therapeutics said today Cystic Fibrosis Foundation Therapeutics has agreed to provide $3 million to fund research and development of a new messenger RNA drug that could be…

[[Click headline to continue reading.]]

Woodcock: New Approvals Show FDA Is Adapting to Precision Medicine

May 30, 2017 – 7:57 am

The randomized controlled trial has long been held up as the gold standard for testing new drugs. But the nation’s top drug evaluator, Janet Woodcock, believes they aren’t necessary for all new…

[[Click headline to continue reading.]]

On ASCO’s Eve, Experts Fret Over Backlash to Cancer Combo Frenzy

May 30, 2017 – 3:05 am

When thousands of cancer researchers from around the world gather in Chicago this weekend for the American Society of Clinical Oncology’s annual meeting, drugs that fight tumors by boosting a…

[[Click headline to continue reading.]]

Bio Roundup: Skinny Cuts, Genomic Approvals, Unfrozen FDA & More

May 26, 2017 – 2:55 am

Team Trump unveiled its 2018 federal spending proposal—the so-called “skinny budget”—with health and science in the crosshairs. The NIH is looking at a 22 percent cut and the FDA 31…

[[Click headline to continue reading.]]

Amid Budget Concerns, NIH Preps Beta Test for Precision Medicine Plan

May 25, 2017 – 4:46 am

An ambitious plan to recruit 1 million U.S. volunteers and amass a treasure trove of their health information will start next week with a “beta test” that health officials hope to eventually expand…

[[Click headline to continue reading.]]

Unconventional Partners, Like FDA, Can Drive Adoption of New Tech

May 23, 2017 – 11:00 pm

We’ve heard it time and again. Drug development is too expensive, takes too long, and many drug candidates that show promise in preclinical trials end up failing because testing methods don’t predict…

[[Click headline to continue reading.]]

Gottlieb Says FDA’s “Regulatory Tools” Can Help Fight Opioid Abuse

May 23, 2017 – 3:01 pm

The FDA considers how safe and effective a new drug is before approving it. But for addictive opioid painkillers, which have triggered a massive public health crisis, should the agency also weigh the…

[[Click headline to continue reading.]]

FDA Landmark Nod: Cancer Drug To Match Tumor Genes, Not Tissue Type

May 23, 2017 – 1:23 pm

For many years, doctors and researchers have known that cancers in different parts of the body can share genetic abnormalities. For the first time, the FDA has approved a drug based on those…

[[Click headline to continue reading.]]